Interleukin-5 inhibitors are linked to faster corticosteroid tapering and discontinuation in patients with drug reaction with eosinophilia and systemic symptoms, a study reports.
Medscape Medical News
Source link
Interleukin-5 inhibitors are linked to faster corticosteroid tapering and discontinuation in patients with drug reaction with eosinophilia and systemic symptoms, a study reports.
Medscape Medical News
Source link